The University of Texas Health Science Center, Houston
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center, Houston sits in the top decile of US sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center, Houston: 732 sponsored US clinical trials, 144 recruiting.
The University of Texas Health Science Center, Houston sponsors 732 registered US clinical trials on ClinicalTrials.gov, 144 of them currently recruiting, and 436 completed. 98 of these trials are in Phase 3-4 (later-stage) and 139 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 8 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center, Houston ranks in the top decile of sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
436 of 521 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
732 total, page 7 of 15
Sustainable Culturally Adapted Nutrition (SCAN) Program
NCT07220057
Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults with Recurrent or Residual Posterior Fossa Ependymoma
NCT04958486
A Telerehabilitation Program for SCI
NCT04977037
Management of Depression and Social Isolation in Older Adults With Dementia With Home-based Telehealth Delivered Behavioral Activation + Caregiver Facilitation.
NCT04915040
Exenatide for Treating Cocaine Use Disorder
NCT04941521
Feasibility and Efficacy of Remotely Monitored Home-based Listening to Preferred Music for Pain in Older Adults With Low Back Pain
NCT04644757
VALES+Tú: Targeting Psychosocial Stressors to Reduce Latino Day Laborers (LDL) Injury Disparities
NCT04800757
Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging
NCT05018247
Preemptive Analgesia With Celecoxib for Acute Dental Pain Management
NCT04790812
A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1)
NCT04750525
A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 3)
NCT04751526
A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 2)
NCT04750538
Implementing a Nurse-Driven Aromatherapy Protocol to Decrease the Effect of Postoperative Nausea and Vomiting
NCT04822844
Subacromial Bursa Re-Implantation After Rotator Cuff Repair
NCT04634084
Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O)
NCT04639973
Fabrication of Naso-alveolar Molding (NAM) Appliance in Cleft Lip and Palate (CLP) From Digital Magnetic Resonance Imaging (MRI) Face Scan
NCT04369638
Assessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease
NCT04591171
Comparison of Operating Room Time Length With the Use of Virtual Surgical Planning Versus Conventional Treatment of Mandible Fractures
NCT04283981
Melatonin for Huntington's Disease (HD) Gene Carriers With HD Related Sleep Disturbance - a Pilot Study
NCT04421339
Connecting Seniors to Care
NCT04581317
Deep Learning Enabled Endovascular Stroke Therapy Screening in Community Hospitals
NCT05838456
Middle School Cluster Randomized Controlled Trial (RCT) to Evaluate E-Cigarette Prevention Program: CATCH My Breath
NCT04843501
Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease
NCT04506073
Randomized Trial of a Data-driven Technical Assistance System for Drug Prevention Coalitions
NCT04592120
Facial and Body Motion Technology and Stroke
NCT04592627
Truncal Ultrasound Guided Regional Anesthesia for Implantation and Revision of Automatic Implantable Cardioverter Defibrillators (AICDs) and Pacemakers in Pediatric Patients
NCT04184349
The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures
NCT04198129
The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)
NCT04941742
DynaCleft® Effects on Soft Tissues and on Quality of Life for Incomplete Unilateral Cleft Lip Infants
NCT04455035
Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
NCT04478071
Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis
NCT04182672
Impact of Daily, Digital and Behavioral Tele-health Tapering Program for Perioperative Surgical Patients Exposed to Opioids and Benzodiazepines.
NCT04787692
Ketamine for Acute Pain Management After Trauma
NCT04129086
Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials
NCT04115098
Estrogen and Fear in PTSD
NCT04192266
Utilizing Activity Trackers to Promote Physical Activity in People With Epilepsy: Can we Make a Difference?
NCT04357912
A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks (QLB)vs Intrathecal Morphine(ITM) for Post Cesarean Section Pain
NCT04368364
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
NCT04387201
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
NCT04369950
Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults with Recurrent Medulloblastoma
NCT04315064
Virtually Assisted Home Rehabilitation After Acute STroke (VAST-rehab)
NCT05659784
Ambulation for Latency During Expectant Management of PPROM
NCT04230967
The Left Ventricular Assist Device (LVAD) Off or On Pump Implantation Study
NCT04219618
Surgical Stabilization for Rib Fractures
NCT04081233
Clinical and Microbiologic Outcomes of aPDT in the Non-surgical Treatment of Implant Inflammation
NCT04187053
Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome
NCT04064684
Management of Chronic Pain and PTSD in Gulf War Veterans With tDCS+Prolonged Exposure
NCT04236284
Intravenous Methocarbamol for Acute Pain After Spine Surgery
NCT06659965
Reducing Costs by Deprescribing Medications
NCT04553107
Decision Aid to Assist Low-Risk Nulliparous Women Considering Induction of Labor At 39 Weeks
NCT04052347
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 84 |
| Phase 3 | 13 |
| Phase 4 | 85 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center, Houston pipeline
144 recruiting of 732 indexed (20% open); 436 completed (60%).
Phase mix: 98 late (III/IV) vs 139 early (I/II) (balanced across stages).
Top condition: Stroke (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center, Houston: open-pipeline peers nationwide
Peers matched on 732 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center, Houston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 732 trials (± recruiting share)
- University of Miami · 721 trials · 20% recruiting
- Sanofi · 713 trials · 10% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- University of Chicago · 20% recruiting · 796 trials
Related
What to do with this The University of Texas Health Science Center, Houston page
732 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center, Houston or any single study.
- 144 of The University of Texas Health Science Center, Houston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Health Science Center, Houston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center, Houston pipeline card: 732 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.